Previous Close | 70.79 |
Open | 69.99 |
Bid | 0.00 x 900 |
Ask | 111.60 x 800 |
Day's Range | 68.85 - 70.12 |
52 Week Range | 50.05 - 78.58 |
Volume | |
Avg. Volume | 277,314 |
Market Cap | 3.46B |
Beta (5Y Monthly) | 1.41 |
PE Ratio (TTM) | 27.18 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.36 (3.38%) |
Ex-Dividend Date | Mar 01, 2024 |
1y Target Est | N/A |
Cohen & Steers, Inc. (NYSE: CNS) has offered and sold 1,007,057 shares of its common stock (the "Shares") through its "at-the-market" equity offering program (the "ATM Program"). The Shares were offered and sold through BofA Securities, as sales agent, at an average price per share of $69.60. The expected net proceeds to Cohen & Steers, after deducting commissions and estimated offering expenses, are approximately $68.4 million. The sales of the Shares are expected to settle on April 24, 2024, s
Cohen & Steers Inc. (NYSE:CNS) will replace Kaman Corp. (NYSE:KAMN) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, April 23. Arcline Investment Management LP is acquiring Kaman in a deal expected to close on April 19, pending final closing conditions.
Cohen & Steers, Inc. (NYSE: CNS) today reported its results for the quarter ended March 31, 2024. The earnings release along with the accompanying earnings presentation can be viewed at Cohen & Steers Reports Results for First Quarter 2024 and on the company's website at www.cohenandsteers.com under "Company—Investor Relations—Earnings Archive."